India's Clinical Trials Market Accelerates - There has been a perceptible change from skepticism to acceptance in how India is viewed for clinical trials. - BioPharm International

ADVERTISEMENT

India's Clinical Trials Market Accelerates
There has been a perceptible change from skepticism to acceptance in how India is viewed for clinical trials.


BioPharm International
Volume 21, Issue 5

REFERENCES

1. Anon. US wants FDA inspectors stationed in India. The Times of India. 2008; Mar 19. Available from: http://timesofindia.indiatimes.com/World/USA/US_wants_FDA_inspectors_stationed_in_India/articleshow/2880547.cms

2. Barnes K. FDA considering establishing Indian presence. Pharma Technologist. 2008. Available from: http://www.in-pharmatechnologist.com/news/ng.asp?n=82658-fda-india-china-inspection/

3. Leavitt M. Secretary Mike Leavitt's blog. Chennai, India. 2008; Jan 7. Available from: http://secretarysblog.hhs.gov/my_weblog/2008/01/chennai-india-w.html

4. Sahoo U, Kermani F. The contract research industry in India. In: Langer ES, editor. Advances in biopharmaceutical technology in India, 1st edition. Rockville, MD:BioPlan Associates, Inc. 2007. Available from: http://www.bioplanassociates.com/

5. Basu I. India's clinical trials and tribulations. The Asia Times. 2004. Available from: http://www.atimes.com/atimes/South_Asia/FG23Df03.html

6. Barnes K. What can CROs do to keep Indian clinical trials ethical? Pharma Technologist. 2006. Available from: http://www.in-pharmatechnologist.com/news/ng.asp?n=68154-chiltern-international-india-clinical-trial-cro/


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here